Home › Pershing Square says Allergan CEO led smear campaign against Valeant
 

Keywords :   


Pershing Square says Allergan CEO led smear campaign against Valeant

2014-10-22 11:21:16| Biotech - Topix.net

Pershing Square Capital Management says that it has uncovered evidence that the management of Allergan Inc. made false and misleading statements about Valeant Pharmaceuticals Inc. as part of a "scorched earth" campaign to thwart the Canadian company's hostile takeover of the California-based maker of Botox. Pershing Square, which is Allergan's largest shareholder and Valeant's ally in the takeover battle, says in a 44-page court filing - which has many portions blacked out and which hasn't been tested in court - that Allergan chief executive David Pyott, who is also chairman of Allergan's board, "personally led the charge and directed much of the misconduct."

Tags: led square campaign ceo

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.09Labelexpo Americas highlights, Maxcess announces acquisition and more
20.09September Cattle on Feed as expected
20.09USDA announces major investment in meat and poultry processing
20.09Atlantic Tropical Weather Outlook
20.09Eastern North Pacific Tropical Weather Outlook
20.09This weeks lesson: Weaning matters in the cattle market
20.09Construction giant collapses putting 2,400 jobs at risk
20.09KANSAI HELIOS Further Expands as System Supplier in Italy
More »